Prostate

Targeted Prostate Cancer Screening Could Benefit Men with Lynch Syndrome

Researchers believe that men with Lynch syndrome could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer.

Prostate

Learning from Prostate Cancer-Detecting Dogs to Improve Diagnostics

New research demonstrates the ability of dogs to detect aggressive prostate cancer from urine samples and suggests that an artificial neural network could learn from this olfactory ability, with an eye toward replicating it in novel detection tools.

Prostate

Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer

Medicare expanded coverage for BRACAnalysis CDx for men with prostate cancer who are eligible or may become eligible for treatment with Lynparza (olaparib).

Molecular Subtyping Signature Predicts Benefit from Chemotherapy in Men with Metastatic Prostate Cancer

Apr 11, 2020 | Cancer, Prostate

A Decipher GRID molecular subtyping signature successfully predicted which patients with mHSPC benefited from adding chemotherapy to androgen deprivation hormone therapy.

System Distinguishes Protein Expression Patterns from Two Prostate Cancer Types

Apr 11, 2020 | Cancer, Prostate

Study data demonstrate the ability of the Adapt system to differentiate exosomes from cancer cell subtypes from the same tumor type.

Study Offers Promise for Multicancer Detection from a Single Blood Draw

Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.

Myriad: NCCN Updates Professional Guidelines for Patients with Prostate Cancer

Mar 25, 2020 | Cancer, Prostate

The Prolaris test from Myriad Genetics was one of only two prognostic tests for prostate cancer recommended by NCCN for the new expanded indications.

AI System Can Detect and Grade Prostate Cancer

Feb 25, 2020 | Cancer, Computing Systems, Information Technology, Middleware & Software, Prostate

The AI system has the potential to solve one of the bottlenecks in today’s prostate cancer histopathology by providing more accurate diagnosis and better treatment decisions.

Decipher Prostate RP Improves Postoperative Management and Outcomes for Prostate Cancer Patients

Feb 17, 2020 | Cancer, Molecular Diagnostics, Prostate

A study showed that when treatment decisions were made and followed based on Decipher Prostate RP genomic test results, patient outcomes were significantly improved.

Paige and Philips to Bring AI to Clinical Pathology Diagnostics

Jan 31, 2020 | Analytical Software Systems, Cancer, Digital Pathology, Prostate

AI-based cancer assessment tools are poised to help pathologists improve the speed and accuracy of cancer diagnostics, ultimately leading to better patient care.

MolDx Issues LCD for Decipher Prostate Biopsy Genomic Test

Jan 30, 2020 | Cancer, Molecular Diagnostics, Prostate, Specimen Collection & Handling

The Medicare LCD provides coverage for the Decipher prostate biopsy genomic test for men with both favorable and unfavorable intermediate-risk prostate cancer.

Enrichment of Human Carcinoma Cells for Molecular Analysis

Dec 11, 2019 | Prostate

The FFPE Tissue Dissociation kit from Miltenyi Biotec offers a standardized protocol for the dissociation of carcinoma samples prior to the enrichment of carcinoma tumor cells for molecular analysis.

Collaborators Launch Unprecedented Effort to Advance Precision Medicine

Dec 5, 2019 | Prostate

Unmatched resources will enable researchers to identify distinctive disease mechanisms in small patient subgroups, supporting the development of custom therapeutic approaches.

Navify Guidelines App Offers Clinicians Guidance for Patients with Common Cancers

Dec 3, 2019 | Prostate, Software

The Navify guidelines app pulls the latest clinical guidance for breast, colorectal, non-small cell lung, and prostate cancers from the National Comprehensive Cancer Network.

Researchers Aim to Create Point-of-Care Biosensor for Prostate Cancer

Oct 21, 2019 | Prostate

The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.

US Preventive Services Task Force Issues Final Recommendation on BRCA-Related Cancer Prevention

Oct 1, 2019 | Breast, Pancreatic, Prostate

Some women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.

Myriad Will Seek FDA Approval of BRACAnalysis CDx as a Companion Diagnostic for Olaparib

Sep 17, 2019 | Prostate

Trial results confirm the potential benefits of using biomarkers to guide care for men with metastatic castration-resistant prostate cancer.

Study: Prolaris Test Accurately Predicts Risk of Prostate Cancer Metastases

Aug 26, 2019 | Prostate

The study’s objective was to evaluate the ability of the Prolaris test and the Prolaris test combined with clinical information to predict a patient’s 10-year risk of progression to metastatic disease.

Category: Prostate

Prostate

Prostate

Prostate